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I N T R O D U C T I O N
Macrophages play an important role in the inflammatory 
responses triggered by hormones and cytokines. These 
cells, which also act as professional antigen-presenting   
cells, modify the cytokine milieu and the intensity of T cell   
signaling. Therefore, macrophages may tune the immune 
response toward inflammation or tolerance. The activa-
tion and proliferation of cells in the immune system are 
modulated by membrane transduction of extracellular 
signals.  Some  interactions  occur  via  the  regulation  of 
transmembrane ion fluxes, and several studies suggest 
that some signaling occurs through ion movements in 
macrophages (Eder, 1998). Thus, macrophages change 
their membrane electrophysiological properties depend-
ing on their state of functional activation (Vicente et al., 
N. Villalonga and M. David, and C. Valenzuela and A. Felipe, contributed 
equally to this paper.
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2003). Changes in membrane potential are among the 
earliest  events  occurring  upon  stimulation  of  macro-
phages, and ion channels underlie the Ca
2+ signal involved 
in  the  leukocyte  activation.  In  this  context,  potassium 
channels indirectly determine the driving force for Ca
2+ 
entry (Cahalan and Chandy, 1997; Panyi et al., 2004).
Voltage-dependent  potassium  (Kv)  channels  have 
the crucial functions in excitable cells of determining 
the resting membrane potential and controlling ac-
tion potentials (Hille, 2001). In addition, they are in-
volved in the activation and proliferation of leukocytes 
(Cahalan and Chandy, 1997; Panyi et al., 2004). Accu-
mulating evidence indicates that Kv channels play a 
pivotal role in the modulation of macrophage immuno-
modulatory responses. Kv channels are tightly regu-
lated during proliferation and activation in macrophages, 
and their functional activity is important for cellular 
responses  (Vicente  et  al.,  2003,  2005,  2006,  2008; 
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Voltage-dependent potassium (Kv) channels play a pivotal role in the modulation of macrophage physiology. Mac-
rophages are professional antigen-presenting cells and produce inflammatory and immunoactive substances that 
modulate the immune response. Blockage of Kv channels by specific antagonists decreases macrophage cytokine 
production and inhibits proliferation. Numerous pharmacological agents exert their effects on specific target cells 
by modifying the activity of their plasma membrane ion channels. Investigation of the mechanisms involved in the 
regulation of potassium ion conduction is, therefore, essential to the understanding of potassium channel func-
tions in the immune response to infection and inflammation. Here, we demonstrate that the biophysical proper-
ties of voltage-dependent K
+ currents are modified upon activation or immunosuppression in macrophages. This 
regulation is in accordance with changes in the molecular characteristics of the heterotetrameric Kv1.3/Kv1.5 chan-
nels, which generate the main Kv in macrophages. An increase in K
+ current amplitude in lipopolysaccharide-acti-
vated macrophages is characterized by a faster C-type inactivation, a greater percentage of cumulative inactivation, 
and a more effective margatoxin (MgTx) inhibition than control cells. These biophysical parameters are related to 
an increase in Kv1.3 subunits in the Kv1.3/Kv1.5 hybrid channel. In contrast, dexamethasone decreased the C-type 
inactivation, the cumulative inactivation, and the sensitivity to MgTx concomitantly with a decrease in Kv1.3 expres-
sion. Neither of these treatments apparently altered the expression of Kv1.5. Our results demonstrate that the 
  immunomodulation of macrophages triggers molecular and biophysical consequences in Kv1.3/Kv1.5 hybrid chan-
nels by altering the subunit stoichiometry.
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date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under a Cre-
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M AT E R I A L S   A N D   M E T H O D S
Cell culture
Raw 264.7 macrophages were used. Cells were cultured in RPMI 
culture media containing 5% FBS supplemented with 2 mM l-glu-
tamine  and  10  U/ml  penicillin  and  streptomycin.  Cells  were 
grown in 100-mm tissue culture dishes for sample collection and 
on noncoated glass coverslips for electrophysiology. In some ex-
periments, Raw 264.7 cells were incubated with 100 ng/ml LPS 
and 1 µM DEX (Sigma-Aldrich) for 24 h.
RNA isolation, reverse transcription (RT)-PCR analysis,  
and real-time PCR
Total RNA from rat tissues (brain and heart), Jurkat T cells, L6E9 
myoblasts, and Raw 264.7 macrophages were isolated using the 
Tripure reagent (Roche). All animal handling was approved by 
the ethics committee of the University of Barcelona in accordance 
with European Union regulations. RNA was treated with DNase I, 
and PCR controls were performed in the absence of RT. cDNA 
synthesis was performed using transcriptor RT (Roche) with a 
random hexanucleotide and oligo dT according to the manufac-
turer’s instructions. Once cDNA was synthesized, the conditions 
were set for further PCR: 92°C for 30 s, 55°C for 1 min, and 72°C 
for 2 min. These settings were applied for 30 cycles. Primer se-
quences and accession numbers were: Kv1.3 (GenBank accession 
number  M30441),  F:  5-CTCATCTCCATTGTCATCTTCTGA-3 
and R: 5-TTGAATTGGAAACAATCAC-3 (base pairs length: 718); 
Kv1.5 (GenBank accession number AF302768), F: 5-GGATCACTC-
CATCACCAG-3 and R: 5-GGCTTCCTCCTCTTCCTTG-3 (base 
pairs length: 334). 10 µL from the final RT-PCR reactions was 
electrophoresed in a 1% agarose TBE gel (40 mM Tris, 20 mM 
acetic acid, and 1 mM EDTA, pH 8.0).
Real-time  PCR  was  performed  using  a  LightCycler  machine 
(Roche) with LightCycler FastStart DNA Master
PLUS SYBR Green I 
(Roche), according to the manufacturer’s instructions. PCR prim-
ers were: Kv1.5, F: 5-TCCGACGGCTGGACTCAATAA-3 and R: 
5-CAGATGGCCTTCTAGGCTGTG-3  (base  pairs  length:  133); 
Kv1.3,  F:  5-AGTATATGGTGATCGAAGAGG-3  and  R:  5-AGT-
GAATATCTTCTTGATGTT-3 (base pairs length: 136). The reac-
tions were performed under the following conditions: 95°C for 5 
s, 55°C for 8 s, and 72°C for 9 s, preceded by 10 min at 95°C and 
followed by 10 min at 95°C. Melting curves were performed to 
verify the specificity of the product, and 18S (GenBank accession 
number X00686; F: 5-CGCAGAATTCCCACTCCCGACCC-3 and 
R: 5-CCCAAGCTCCAACTACGAGC-3; base pairs length: 212) 
was included as an internal reference, as described previously. Re-
sults were analyzed with Light Cycler software 3.5 (Roche). For 
each primer set, a standard curve was made and the slope factor 
calculated.  Values  were  normalized  to  the  corresponding  18S. 
The corresponding real-time PCR efficiency (E) of one cycle in 
the exponential phase was calculated according to the equation: 
E = 10
(1/slope). The normalized Kv1.5/Kv1.3 ratio was calculated as 
follows: Ratio = (1+E)
∆Ct(Kv1.5)/(1+E)
∆Ct(Kv1.3), where Ct signifies the 
threshold cycle.
Crude membrane preparations and Western blot
Cells were washed twice in cold PBS and lysed on ice with lysis 
solution (1% Triton X-100, 10% glycerol, 50 mM HEPES, pH 
7.5, and 150 mM NaCl) supplemented with 1 µg/ml aprotinin, 
1 µg/ml leupeptin, 1 µg/ml pepstatin, and 1 ml phenylmethyl-
sulfonyl  fluoride  as  protease  inhibitors.  To  obtain  enriched 
membrane preparations, homogenates were centrifuged at 3,000 g 
for 10 min, and the supernatant was further centrifuged at 
150,000 g for 90 min. The pellet was resuspended in 30 mM 
HEPES, pH 7.4, and protein content was determined by the Bio-
Rad  Protein  Assay  (Bio-Rad  Laboratories).  Samples  were  ali-
quoted and stored at 80°C.
  Villalonga et al., 2007). Proliferation and activation 
trigger an induction of the outward K
+ current that is 
under transcriptional, translational, and posttransla-
tional control (Vicente et al., 2003). Assigning spe-
cific K
+ channel clones to native currents is difficult 
because this complexity is further enhanced by the 
heteromultimeric  assembly  of  different  Kv  subunits 
(Vicente et al., 2006). Kv1.5 coassociates with Kv1.3 to 
generate  functional  Kv1.3/Kv1.5  heterotetrameric 
channels  in  macrophages.  In  response  to  different 
physiological stimuli, changes in the oligomeric com-
position of functional Kv could have a crucial effect 
on intracellular signals, determining the specific mac-
rophage response (Vicente et al., 2003, 2006, 2008; 
Villalonga et al., 2007).
Bacterial lipopolysaccharide (LPS) activates macro-
phages, leading to the secretion of bioactive molecules 
such as cytokines (e.g., TNF-) and nitric oxide (NO) 
(Soler et al., 2001). However, there is tight regulation 
of signaling events to avoid an exaggerated response 
by macrophages during infection and injuries. These 
mechanisms  include  the  release  of  glucocorticoids 
(GCs) by the adrenal gland. GCs, which exert their 
antiinflammatory action, in part, by influencing mac-
rophages, inhibit the expression of inflammatory me-
diators, and thus are used in the treatment of many 
inflammatory diseases (Lloberas et al., 1998). GCs may 
trigger long-term changes in cell excitability by regu-
lating K
+ channel gene expression. Thus, while mac-
rophage  activation  induces  Kv1.3,  dexamethasone 
(DEX), a GC receptor agonist, inhibits Kv1.3 in T cells 
but differentially regulates Kv1.5 in several cells and 
tissues  (Attardi  et  al.,  1993;  Takimoto  et  al.,  1993; 
  Takimoto and Levitan, 1994, 1996; Levitan et al., 1996; 
Lampert et al., 2003). Experimental evidence indicates 
that in macrophages, the major Kv is mainly a hetero-
tetrameric Kv1.3/Kv1.5 channel (Vicente et al., 2006; 
Villalonga  et  al.,  2007).  Therefore,  the  analysis  of 
macrophage hybrid channels under immunomodula-
tion has physiological relevance. The aim of the pres-
ent  work  was  to  investigate  heteromeric  Kv1.3/Kv1.5 
channels in macrophages and to analyze the molecu-
lar and biophysical consequences upon activation and 
immunosuppression.
Here,  we  demonstrate  that,  in  contrast  to  LPS,   
DEX inhibits Kv1.3. Neither LPS nor DEX apparently 
regulated Kv1.5 in macrophages, leading to different 
oligomeric Kv1.3/Kv1.5 channels. While LPS-induced 
activation increased, DEX diminished the Kv1.3 ratio 
in the complex. Protein and mRNA regulation corre-
lated with the electrophysiological and pharmacologi-
cal properties of the K
+ currents upon activation and 
immunosuppression. Our results demonstrate that dif-
ferent channel compositions change biophysical prop-
erties and could physiologically tune the membrane 
potential to achieve precise immune responses.  Villalonga et al. 137
Thereafter, capacitance and series resistance compensation were 
optimized and, usually, 80% compensation of the effective ac-
cess resistance was obtained. Electrodes were filled with an in-
tracellular pipette solution containing (in mM): 80 K-aspartate, 
50 KCl, 3 phosphocreatine, 10 KH2PO4, 3 MgATP, 10 HEPES-K, 
and 5 EGTA-K, and was adjusted to pH 7.25 with KOH. The bath 
solution contained (in mM): 130 NaCl, 4 KCl, 1.8 CaCl2, 1 MgCl2, 
10 HEPES-Na, and 10 glucose, and was adjusted to pH 7.40 with 
NaOH. Uncompensated series resistances were 4–8 MΩ, as cur-
rents evoked were <1 nA; voltage errors from uncompensated se-
ries resistance were <2 mV.
Inactivation was fit to an exponential process, using an equa-
tion of the form:
  y = − +  A exp  t    C 1 1 ( / ) τ  
where  is the system time constant, A is the amplitude, and C is 
the baseline value. To analyze the cumulative inactivation, cur-
rents were elicited by a train of eight depolarizing voltage steps of 
200 ms to + 60 mV once every 400 ms. The voltage dependence of 
activation curves were fitted with a Boltzmann equation:
  y   1 1   exp = + − − ( ) ( )     / / , V V k h  
in which k represents the slope factor, V the membrane potential, 
and Vh the voltage at which 50% of the channels are open (Fran-
queza et al., 1998; González et al., 2001).
The number of channels per cell and their surface density were 
calculated from the conductance of Kv1.3 (13 pS) and Kv1.5 (8 
pS) following the Kv1.3/ Kv1.5 ratio obtained from real-time PCR 
results following the equation:
  G  Imax = − ( ) / , V VK  
where G represents the total conductance, Imax is the peak ampli-
tude,  V  is  the  voltage  applied,  and  VK  is  the  K
+  equilibrium 
potential.
To characterize the K
+ current pharmacologically, 750 pM mar-
gatoxin (MgTx; Alomone Labs) was added to the external solu-
tion (Vicente et al., 2003, 2006). Toxin was reconstituted at 10 µM 
in Tris buffer (0.1% BSA, 100 mM NaCl, and 10 mM Tris, pH 7.5). 
Solutions were perfused by using a gravity-flow perfusion setup. 
The inhibition by MgTx was defined by the remaining current 
fraction in the presence and absence of the toxin. All recordings 
were performed at room temperature (20–23°C).
Lentivirus infection
To knock down Kv1.3 in Raw macrophages, Kv1.3 shRNA (mouse) 
lentiviral (LTV) particles were used (Santa Cruz Biotechnology, 
Inc.). Cells were cultured in 12-well dishes to get 50% conflu-
ence and infected with 5,000 infectious units in the presence of   
2 µg/ml polybrene (Sigma-Aldrich). 24 h after infection, the me-
dium was replaced by regular culture medium supplemented with 
10  µg/ml  puromycin  (Sigma-Aldrich)  for  clone  selection.  Se-
lected clones were maintained with 2 µg/ml puromycin. Specific 
silenced  expression  of  Kv1.3,  but  not  Kv1.5,  was  confirmed  by 
Western blot. Control shRNA LTV particles containing a scram-
bled sequence were also used (not depicted).
Statistics
Values are expressed as the mean ± SEM. The significance of dif-
ferences was established by Student’s t test or Pearson product-
moment correlation coefficient with a two-tailed p-value (PRISM 
4.0; GraphPad Software, Inc.) when indicated. The curve-fitting 
procedure used a nonlinear least-squares (Gauss-Newton) algo-
rithm; results were displayed in linear format. Goodness of fit was 
Crude  membrane  protein  samples  (50  µg)  were  boiled  in 
Laemmli SDS loading buffer and separated on 10% SDS-PAGE. 
Next,  they  were  transferred  to  nitrocellulose  membranes  (Im-
mobilon-P; Millipore) and blocked in 5% dry milk–supplemented 
0.2% Tween 20 PBS before immunoreaction. Filters were immuno-
blotted with antibodies against Kv1.3 (1/200; Alomone Labs), 
Kv1.5 (1/500; Alomone Labs), and inducible NO synthase (iNOS; 
1/500; Santa Cruz Biotechnology, Inc.). As a loading and transfer 
control, a monoclonal anti– actin antibody (1/5,000; Sigma-
  Aldrich) was used. The specificity of Kv1.3 and Kv1.5 commercial 
antibodies was tested with control antigen peptides provided by 
the manufacturer. Densitometric analysis of the filters was per-
formed by Phoretix software (Nonlinear Dynamics). Results are 
presented as the mean ± SEM of each experimental group.
Electron microscopy
Macrophages were fixed in 4% paraformaldehyde (PFA)/0.2% 
glutaraldehyde (GA) in PBS for 30 min at room temperature, 
and then left in 2% PFA/0.1% GA in PBS overnight at 4°C. Fixa-
tion was stopped by washing with 20 mM glycine in PBS. Cells 
were scraped and collected in tubes (Eppendorf) with 12% gela-
tin. After solidifying on ice, gelatin blocks were infiltrated in 2.3 M 
sucrose in PBS overnight at 4°C. Blocks were frozen in liquid nitro-
gen. Ultrathin cryosections were obtained using Leica ULTRA-
CUT EM FCS at 118°C and subjected to immunogold labeling. 
Cryosections were incubated at room temperature on drops of 
2% gelatin in phosphate buffer for 20 min at 37°C, followed by 
50 mM glycine in PBS for 15 min and 5% normal goat serum 
(NGS ) in PBS for 10 min. Then they were incubated with anti-
Kv1.5 and anti-Kv1.3 polyclonal antibodies in 5% NGS in PBS for 
30 min. After three washes with drops of 5% NGS in PBS for 20 
min, sections were incubated for 60 min using immunoglobulin 
G anti–rabbit coupled to 10- or 15-nm diameter colloidal gold 
particles (Aurion) using a 1:60 dilution in 5% NGS in PBS. This 
was followed by three washes with drops of PBS for 10 min and 
two washes with distilled water. As a control for nonspecific bind-
ing of the colloidal gold–conjugated antibody, the primary poly-
clonal antibody was omitted. Finally, the cryosections were contrasted 
and embedded in a mixture of methylcellulose and uranyl ace-
tate. For the double immunogold, immunolabeling with one of 
the primary antibodies was done. We used the secondary anti-
body conjugated with the small gold (10 nm) in the first immu-
nolabeling procedure. Then, the anti–immunoglobulin G binding 
sites were inactivated using 3% PFA/2% GA in PBS for 2 h. After 
inactivation, the immunolabeling with the other primary anti-
body was done using the secondary antibody conjugated to 15-nm 
gold particles. Primary antibody dilutions were 1:50 in both cases. 
Samples  were  viewed  with  an  electron  microscope  (1010; 
JEOL).
Electrophysiological recordings
Whole cell currents were measured using the patch clamp tech-
nique with an amplifier (Axopatch 1C; Axon Instruments) and 
stored on a personal computer (TD Systems) with an analogue-to-
digital converter (DigiData 1322A; Axon Instruments). pClamp 
version 9 software (Axon Instruments) was used for data acquisi-
tion and analysis. Currents were recorded at room temperature   
(21–23°C) at a stimulation frequency of 0.1 Hz and sampled at 4 kHz   
after anti-alias filtering at 2 kHz. Patch electrodes of 2–4 MΩ were 
fabricated in a puller (P-87; Sutter Instrument Co.) from borosili-
cate glass capillary tubes (GD-1; Narishige). GigaΩ seal formation 
was achieved by suction (2–5 GΩ; n = 12). After seal formation, 
cells were lifted from the bath and the membrane patch was rup-
tured with a brief additional suction. The capacitive transients 
elicited by symmetrical 10-mV steps from 80 mV were recorded 
at 50 kHz and filtered at 10 kHz for subsequent calculations of 
capacitative surface area, access resistance, and input impedance.   138 Immunomodulation of Kv1.3/Kv1.5 channels
  expected, Kv1.3 protein was detected in macrophages 
and Jurkat T cells, whereas Raw cells shared Kv1.5 ex-
pression with L6E9 skeletal muscle myoblasts (Villalonga 
et  al.,  2008).  We  have  recently  shown  that  although 
Kv1.3 may form homotetrameric structures, and may be 
located at the membrane surface, Kv1.5 mostly coassoci-
ates with Kv1.3 to form heterotetrameric channels in 
macrophages  (Vicente  et  al.,  2006;  Villalonga  et  al., 
2007). In addition, the presence of Kv1.5 impairs the 
membrane surface location of the complex (Martínez-
Mármol et al., 2008; Vicente et al., 2008). Electron mi-
croscopic immunocytochemical detection studies with 
specific antibodies showed that although Kv1.3 was de-
tected  at  the  membrane  surface,  many  heteromeric 
structures containing Kv1.5 were located intracellularly 
(Fig.  1  E).  Collectively,  these  data  indicate  that  Raw 
264.7 macrophages have outward delayed rectifier K
+ 
currents that are mainly conducted by Kv1.3 and Kv1.5 
channels.
Immunomodulation of macrophages triggers differential 
biophysical and pharmacological consequences
Once Kv currents were characterized and the molecular 
basis of the responsible channels was identified, we next 
analyzed their biophysical characteristics upon activa-
tion or immunosuppression in macrophages (Fig. 2). 
Raw cells were either activated with LPS or cultured in 
judged by the 
2 criterion and by inspection for systematic non-
random trends in the difference plot. A value of P < 0.05 was con-
sidered significant.
R E S U LT S
Kv1.3 and Kv1.5 generate Kv currents in Raw 264.7 
macrophages
Kv currents were evoked in Raw cells by applying depo-
larizing pulses from a holding potential of 80 mV to 
different depolarizing voltages from 80 to +60 mV in 
10-mV steps (Fig. 1 A). Fig. 1 B plots normalized con-
ductance against test potential. The threshold for acti-
vation was about 20 mV. Vh and k slope were 11.1 ± 2.2 
and 12.3 ± 2.5 mV, respectively. Previous work indicates 
that macrophages exhibit Kv currents mainly generated 
by Kv1.3 and Kv1.5 channels (Vicente et al., 2003, 2005, 
2006, 2008; Villalonga et al., 2007). Therefore, we ana-
lyzed  the  presence  of  these  channels  in  Raw  macro-
phages. To analyze the K
+ channel mRNA expression, 
we performed RT-PCR analysis. Mouse brain and heart 
RNAs were used as positive controls for Kv1.3 and Kv1.5, 
respectively. Fig. 1 C demonstrates that Kv1.3 and Kv1.5 
mRNA were detected in Raw macrophages in the pres-
ence (+RT), but not in the absence, of the retrotrans-
criptase (RT). In addition, a specific Kv1.3 and Kv1.5 
signal  was  obtained  by  Western  blot  (Fig.  1  D).  As 
Figure 1.  Macrophages express Kv1.3 and Kv1.5. Cells were held at 80 mV, and pulse potentials were applied as indicated. (A) Rep-
resentative traces of delayed rectifier K
+ currents. (B) Steady-state activation curve of the outward current. Conductance was plotted 
against test potentials. (C) mRNA expression of Kv1.3 and Kv1.5 in Raw 264.7 cells. Mouse brain and heart RNA were used as positive 
controls for Kv1.3 and Kv1.5, respectively. PCR reactions were performed in the presence (+) or absence () of the retrotranscriptase 
reaction. (D) Kv1.3 and Kv1.5 protein expression in Raw macrophages. Jurkat T lymphocytes and L6E9 skeletal muscle myoblasts were 
used as positive controls for Kv1.3 and Kv1.5, respectively. (E) Immunocytochemical electron microscopic detection of Kv1.3 and Kv1.5 
proteins. Arrows show specific channel protein localization. Black arrow, Kv1.3; white arrow, Kv1.5; bar, 0.20 µm.  Villalonga et al. 139
While at +60 mV, resting cells expressed 60 channels/
cell with a density of 0.018 channel/µm
2, and activated 
cells showed 82 channels/cell and 0.04 channel/µm
2 
(P < 0.05 and P < 0.001 vs. control for number and den-
sity, respectively). On the other hand, DEX did not mod-
ify the number or the density of the channels.
Different Kv1.3/Kv1.5 hetero-oliogomeric structures 
lead to distinct pharmacological properties of the chan-
nel (Vicente et al., 2006). Although Kv1.3 and Kv1.3/Kv1.5 
heteromeric channels are sensitive to MgTx, a highly spe-
cific Kv1.3 blocker, Kv1.5 homotetrameric structures are 
resistant (Vicente et al., 2006). As described previously 
(Villalonga et al., 2007), pharmacological analysis of the 
Kv currents in the presence of MgTx demonstrated that K
+ 
currents were fully sensitive to MgTx in Raw macrophages 
(not depicted). When K
+ currents were analyzed in the 
presence of 750 pM MgTx, a concentration close to the 
IC50 of the toxin (Villalonga et al., 2007), K
+ currents were 
inhibited (Fig. 3 A). The efficiency of MgTx in LPS-treated 
macrophages was noticeable, as the majority of LPS-de-
pendent, induced K
+ current was blocked (Fig. 3 A). The 
percentage of inhibition of the peak current density at 
+60 mV in the presence of MgTx (Fig. 3 B) indicated that 
the  presence  of  DEX.  Fig.  2  A  shows  representative 
traces from a single depolarizing 250-ms pulse potential 
from 80 to +60 mV. Unlike DEX, LPS slightly increased 
the peak current amplitude. However, the inactivation 
time  course  was  clearly  affected  by  both  treatments. 
While LPS accelerated, DEX slowed it. The effects of 
LPS and DEX on Raw cells were analyzed as the changes 
in current density observed at different test potentials 
during the application of 250-ms depolarizing pulses 
from 80 to +60 mV in 10-mV steps. The current den-
sity versus voltage relationships are depicted in Fig. 2 B. 
Once the channels opened (above 20 mV), LPS, but 
not DEX, increased currents at all depolarizing voltages 
applied (from 20 to +60 mV). While LPS increased 
peak currents (at +60 mV) up to twofold, DEX slightly 
decreased the current amplitude (Fig. 2 C). This appar-
ent discrepancy between current amplitudes and cur-
rent densities was related to the size of the cell. Raw 
cells incubated with LPS were 40% smaller than con-
trol cells (Fig. 2 D). On the other hand, apparently DEX 
did not modify the cell size.
The number and density of the channels increased dur-
ing LPS-induced activation (Fig. 2, E and F, respectively). 
Figure 2.  Voltage-dependent K
+ currents 
in Raw 264.7 macrophages. (A) Represen-
tative traces of delayed rectifier K
+ currents 
in  control,  LPS-,  and  DEX-treated  cells. 
Macrophages were treated with 100 ng/ml 
LPS and 1 µM DEX for 24 h. Cells were 
held at 80 mV, and currents were elicited 
by a depolarizing pulse to +60 mV (250-ms 
duration). Black trace, control; dark gray 
trace, LPS; light gray trace, DEX. (B) Cur-
rent density (pA/pF) versus voltage rela-
tionship of K
+ currents. Current density was 
calculated as a function of peak amplitude 
and the cell capacitance of each recorded 
cell. (C) Peak current density at +60 mV. 
(D) Cell capacitance (pF) from the same 
cell population from B. (E) Channel den-
sity was calculated from the conductance 
of Kv1.3 (13 pS) and Kv1.5 (8 pS) following 
the real-time PCR results in Fig. 4 and the 
Kv1.3/ Kv1.5 ratio shown in Fig. 8. (F) The 
results in E as a function of the plasma cell 
membrane surface. White (bar or circle), 
control;  black  (bar  or  circle),  LPS;  gray 
(bar or circle), DEX. *, P < 0.05; ***, P < 
0.001 versus control; n > 10 cells per group 
(Student’s t test).140 Immunomodulation of Kv1.3/Kv1.5 channels
absence  or  presence  of  LPS  or  DEX.  Inactivation 
  parameters are useful to evaluate possible differences   
in the tetrameric K
+ channel phenotype. Kv1.3 is well 
while in control cells the current was blocked 44 ± 3%, 
this inhibition was 65 ± 4 and 28 ± 2% in the presence of 
LPS and DEX, respectively (n = 4–6; P < 0.05 vs. control). 
These results further confirm that although Kv1.3 could 
form homomeric channels in macrophages, Kv1.5 mostly 
coassociates with Kv1.3 to generate multiple heteromeric 
structures with distinct pharmacological properties.
Differential expression of Kv1.3 and Kv1.5 upon activation 
and immunosuppression
Fig. 4 A illustrates the Kv1.3 and Kv1.5 gene expression 
after the addition of LPS and DEX. Although Kv1.3 is 
differentially regulated by LPS and DEX, Kv1.5 remained 
almost unchanged. However, although the expression of 
Kv1.3  increased  up  to  2.5-fold  in  LPS-treated  macro-
phages, its expression decreased by 50% in the presence 
of DEX. Similar changes were obtained for the Kv1.3 and 
Kv1.5 protein abundance in macrophages incubated for 
24 h in the presence of LPS and DEX (Fig. 4 B). No dif-
ferences were observed with Kv1.5 throughout the study. 
The expression of the iNOS was used as a marker of mac-
rophage  activation  (Soler  et  al.,  2001).  As  expected, 
iNOS was induced in the presence of LPS, but not DEX. 
Fig. 4 (C and D) represents the quantification of at least 
three independent blots. Collectively, these data indicate 
that LPS-induced activation led to long-term increases in 
current densities of outward K
+ currents in accordance 
with an induction in Kv1.3 mRNA and protein expres-
sion. On the contrary, DEX, which slightly decreased 
current densities, decreased Kv1.3 expression. Because 
neither LPS nor DEX incubation produced K
+ currents 
resistant to MgTx (not depicted), our results are consis-
tent with an increased or decreased number of Kv1.3 
subunits, either as homomeric Kv1.3 or hybrid Kv1.3/
Kv1.5 channels upon activation or immunosuppression.
Inactivation properties are differentially regulated during 
immunomodulation
As demonstrated (Fig. 2 A), Kv currents recorded from 
Raw cells inactivate with a different time course in the 
Figure 3.  MgTx inhibits K
+ currents in 
macrophages. Cells were held at 80 
mV, and pulse potentials were applied 
as indicated in Fig. 1 in the presence or 
absence of 750 pM MgTx. (A) Current 
density  (pA/pF)  versus  voltage  rela-
tionship of K
+ currents. Current den-
sity was calculated as a function of the 
peak  amplitude  and  the  capacitance 
for each recorded cell in the presence 
(black  symbols)  and  absence  (white 
symbols) of MgTx. (B) Percentage of 
MgTx  inhibition  at  the  peak  current 
density (+60 mV). White bar, control; 
black bar, LPS; gray bar, DEX. *, P < 
0.05 versus control; n = 4–6 cells per 
group (Student’s t test).
Figure  4.  Activation and immunosuppression differentially reg-
ulates Kv1.3 and Kv1.5 in macrophages. Control cells were incu-
bated for 24 h in the presence of LPS and DEX. Samples were 
collected after the addition of agents, and Kv1.3 and Kv1.5 expres-
sion was analyzed. (A) Kv1.3 (white bar) and Kv1.5 (black bar) rel-
ative mRNA expression by real-time PCR. Values are the mean ± 
SEM (n = 4). Significant differences were only found with Kv1.3 (*,   
P < 0.05; **, P < 0.01 vs. control; Student’s t test). Using standard 
curves, fold variation in arbitrary units (A.U.) was normalized to 
18S relative quantity (RQ) as follows: (Kv1.5 or Kv1.3 RQ (LPS or 
DEX)/18S RQ (LPS or DEX))/(Kv1.5 or Kv1.3 RQ (control)/18S 
RQ (control)). (B) Kv1.3, Kv1.5, and iNOS protein expression in 
macrophages. Representative blots are shown. (C and D) Kv1.3 
(C) and Kv1.5 (D) quantification of data in B. Values were nor-
malized to  actin. In all cases, arbitrary units are standardized 
to the control value in the absence of treatment. White bars, con-
trol; black bars, LPS; gray bars, DEX. Values are the mean ± SEM 
of at least three independent experiments. *, P < 0.05; **, P < 0.01 
versus control (Student’s t test).  Villalonga et al. 141
became  much  slower  in  Raw  cells  treated  with  DEX 
(2,940 ± 70 ms; n = 5; P < 0.05 vs. control) (Fig. 5 B). 
Our results further support the notion that Kv currents 
generated  upon  depolarization  in  macrophages  are 
generated by Kv channels with different subunit stoichi-
ometry upon activation or immunosuppression.
Cumulative inactivation of certain K
+ channels is char-
acterized by an inactivation that accumulates during re-
petitive  depolarizing  pulses  because  recovery  during 
the interpulse interval is incomplete (Grissmer et al., 
1994). Fig. 6 (A–C) depicts representative traces of K
+ 
characterized by its C-type inactivation, which is absent 
in Kv1.5 (Po et al., 1992; Gutman et al., 2005). Because 
C-type inactivation involves the cooperative interaction 
of all four subunits, this parameter could be used to de-
termine  heterotetramers  (Panyi  et  al.,  1995).  Fig.  5 
shows the time course of K
+ current inactivation after 
applying a depolarizing pulse from 80 to +60 mV for   
5 s (Fig. 5 A). Although K
+ currents inactivated with a 
time constant of inactivation of 1,630 ± 40 ms (n = 5) in 
control macrophages, in LPS-treated cells, it was 885 ± 
35 ms (n = 6; P < 0.05 vs. control). However, this process 
Figure  5.  Biophysical  properties  of  the 
C-type inactivation of K
+ currents in Raw 
macrophages.  (A)  Representative  traces 
of C-type inactivation. Cells were held at 
80 mV, and pulse potentials were applied 
from 80 to +60 mV for 5 s. For compari-
son, the intensity in each group has been 
normalized. (B) Time constant of inacti-
vation (). Values are the mean ± SEM of 
at least 10 independent cells. *, P < 0.05 
versus control (Student’s t test).
Figure 6.  Biophysical properties of the cumulative inactivation of K
+ currents in Raw macrophages. (A–C) Representative traces show-
ing cumulative inactivation of K
+ currents. Cells were held at 80 mV, and currents were elicited by a train of eight depolarizing voltage 
steps (200-ms duration) to +60 mV once every 400 ms. (A) Control. (B) LPS. (C) DEX. (D) Percentage of cumulative inactivation at the 
peak current. The percentage was calculated as a result of the difference between the peak current at the first pulse and the remain-
ing current at the last. (E) Plot of normalized current area versus pulse. The current amplitude became progressively smaller from the 
first trace to the last in control and LPS, but not in DEX-treated macrophages. Inset represents K
+ current area decay from control and 
DEX-treated macrophages for magnification. Values are the mean ± SEM of at least 10 independent cells. **, P < 0.01 versus control 
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Kv1.3 gene silencing in Raw 264.7 macrophages 
counteracts LPS-dependent biophysical changes
LPS and DEX regulated Kv1.3 expression in agreement 
with changes in electrophysiological properties, which 
suggest changes of Kv1.3 subunits either as Kv1.3 homo-
tetrameric  or  Kv1.3/Kv1.5  heterotetrameric  channels. 
Therefore, we next analyzed whether Kv1.3 gene silenc-
ing  impairs  LPS  and  DEX  modulation.  LTV  shRNA 
Kv1.3  infection  in  macrophages  led  to  an  65%  de-
crease in Kv1.3 protein expression (Fig. 7 A). Although 
macroscopic outward K
+ currents were similar between 
control  (Raw)  and  LTV-infected  cells  (Raw-LTV),  K
+ 
currents in LTV cells were slightly lower and inactivate 
less than control (Fig. 7 B). Fig. 7 C demonstrates that 
neither LPS nor DEX modulated the current density in 
LTV cells. However, LPS still triggered changes in the 
cell size (Fig. 7 D). Unlike in Raw macrophages, 5-s 
pulses  did  not  inactivate  currents  in  Raw-LTV  cells   
(Fig. 7 E). In addition, LPS and DEX did not significant 
modify the time constant for inactivation in LTV cells. 
currents in macrophages in the presence and absence 
of LPS or DEX during the application of a train of re-
petitive pulses, each of 200 ms at a frequency of 4 Hz. 
The standardized peak current amplitude rapidly di-
minished in control Raw cells (Fig. 6 A). In LPS-acti-
vated  macrophages,  the  accumulation  of  inactivation 
increased (Fig. 6 B). However, this was much less appar-
ent in Raw cells treated with DEX (Fig. 6 C). Although 
the cumulative inactivation was 12 ± 3% (n = 7) in con-
trol cells, in LPS-induced cells, activation rose to 31 ± 
6% (n = 7; P < 0.01 vs. control) (Fig. 6 D). In contrast, 
incubation with DEX led to a marked decrease, and cu-
mulative inactivation was almost absent (0.5 ± 3; n = 7;   
P < 0.01 vs. control). The normalized area of the K
+ cur-
rents demonstrated that, contrary to DEX, cumulative 
inactivation was noticeable in control and LPS-activated 
macrophages from the first pulse (Fig. 6 E). Once again, 
these results indicate that Kv1.5 associates with Kv1.3, 
forming  different  heteromeric  structures,  and  this   
stoichiometry may be changed by different stimuli.
Figure  7.  Kv1.3  gene  silencing  abolishes  LPS- 
and  DEX-dependent  biophysical  changes  in 
macrophages.  LTV  shRNA  (mouse)  Kv1.3  was 
used to silence the Kv1.3 gene in Raw 264.7 mac-
rophages.  (A)  A  representative  Western  blot. 
Note that although Kv1.3 expression is lower in 
LTV, relative Kv1.5 abundance was similar in both 
groups.  Raw,  control  macrophages;  Raw-LTV, 
LTV-silenced Kv1.3 macrophages. (B) Represen-
tative traces of K
+ currents in macrophages. Cells 
were held at 80 mV, and currents were elicited 
by a depolarizing pulse to +60 mV (250-ms dura-
tion). (C) Current density (pA/pF) versus volt-
age relationship of K
+ currents. Current density 
was calculated as a function of peak amplitude 
and the capacitance of each recorded cell in the 
presence or absence of LPS and DEX. (D) Cell 
capacitance (pF) from the same cell population 
from B. (E) Representative traces of C-type inac-
tivation. Cells were held at 80 mV, and pulse 
potentials were applied from 80 to +60 mV for 
5 s. For comparison, the intensity in each group 
has been normalized. (F) Percentage of cumula-
tive inactivation at the peak current. Cells were 
held at 80 mV, and currents were elicited by a 
train of eight depolarizing voltage steps (200-ms   
duration) to +60 mV once every 400 ms. The per-
centage was calculated as a result of the difference 
between the peak current at the first pulse and 
the remaining current at the last. (D and F) Raw,   
no infected Raw macrophages; Raw-LTV, lenti-
virus-infected Raw cells; white bars, control (no 
treatment);  black  bars,  LPS;  gray  bars,  DEX. 
Values are the mean ± SEM of six to eight in-
dependent  cells.  *,  P  <  0.001  versus  control 
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with these biophysical changes. The presence of Kv1.3 at 
the membrane surface assures the specific activation, 
and the presence of Kv1.5 in the hybrid channel shifts 
the  activation  curve  toward  depolarizing  potentials 
  (Vicente et al., 2006). Indeed, a +25-mV change modi-
fies interleukin 2 production, thus reducing the activa-
tion  and  the  antibody  production  by  lymphocytes 
(Freedman et al., 1992). In addition, as we have sug-
gested previously and further confirmed here, Kv1.3/ 
Kv1.5 heteromers tend to be more intracellular, fine-
tuning the response (Vicente et al., 2008). Thus, Kv1.5 
impairs the location of Kv1.3 in lipid raft microdomains, 
but  this  is  partially  reversed  by  incubation  with  LPS 
(Martínez-Mármol et al., 2008; Vicente et al., 2008). In 
fact, lipid rafts play a role in LPS-induced signaling in 
macrophages (Olsson and Sundler, 2006).
Kv1.3 is crucial to the immune response. However, the 
role of Kv1.5 in the myeloid lineage is under debate. Pyo 
et al. (1997) demonstrated that outward K
+ channels in-
duced by LPS are immunologically related to Kv1.5. Fur-
thermore, although some studies support the unique 
expression of Kv1.3 without an apparent function, oth-
ers claim a pivotal role for Kv1.5 (Mackenzie et al., 2003; 
Park et al., 2006). However, most of the literature de-
scribes Kv1.3 and Kv1.5 in the myeloid lineage, and an 
association of the two proteins has been demonstrated 
(Kotecha  and  Schlichter,  1999;  Vicente  et  al.,  2003, 
2005, 2006, 2008; Fordyce et al., 2005; Judge et al., 2006; 
Mullen et al., 2006; Pannasch et al., 2006; Villalonga et 
al., 2007). Indeed, microglia activation by LPS involves 
the activation of Kv1.5 and Kv1.3 (Pannasch et al., 2006). 
In Kv1.5
/ mice, the LPS-induced NO production is 
completely absent, indicating that Kv1.5 expression must 
be necessary for NO production (Pannasch et al., 2006). 
Just as in myoblasts, Kv1.5 could have a key role when 
predominant (Villalonga et al., 2008). Although Kv1.3 
may form homotetramers, Kv1.5 seems to be mostly 
  involved  in  heteromers  and  could  be  essential  for   
the function of the complex (Pannasch et al., 2006; 
  Villalonga et al., 2007). Similar to what we found in mac-
rophages, DEX inhibits Kv1.3 in Jurkat T cells, thereby 
avoiding Ca
2+ entry through Ca
2+ release–activated Ca
2+ 
channels (Lampert et al., 2003). Because an increase in 
Ca
2+ ions is essential to leukocyte activation (Cahalan 
and  Chandy,  1997),  DEX  exerts  antiinflammatory  ef-
fects. In addition, down-regulation of Kv1.3 impairs T 
cell volume regulatory mechanisms, which are reversed 
by transfection with Kv1.3 (Lampert et al., 2003). How-
ever, this is not the case in macrophages. Cell volume 
regulatory mechanisms are important during the mac-
rophage immune response. The Kv1.3/Kv1.5 composi-
tion  of  the  channel  assures  cell  volume  control.  We 
found that DEX did not exert changes in the cell size. 
However,  unlike  inactivating  channels  such  as  Kv1.4, 
Kv1.5 is involved in regulatory volume control (Felipe   
et al., 1993). In this context, DEX up-regulates aquaporins 
  Cumulative inactivation was also affected in LTV cells 
(Fig. 7 F). Although LPS triggered an increase in Raw 
macrophages, DEX, LTV, and LTV-treated cells showed 
no inactivation. These results show that (a) K
+ currents 
in LTV cells did not recapitulate Kv1.3 characteristics, 
and (b) LPS and DEX incubation did not alter the elec-
trophysiological phenotype.
Our results suggest that LPS and DEX regulated Kv1.3, 
leading to pharmacologically distinct channels. MgTx 
differentially inhibited K
+ currents upon activation and 
immunosuppression  in  Raw  macrophages  (Fig.  3). 
Therefore, we analyzed Kv currents in Raw-LTV cells in 
the presence of 750 pM MgTx. Unlike Raw control cells, 
Kv currents in Raw-LTV cells were highly resistant to the 
toxin. Thus, peak current densities (+60 mV) were 2.22 ± 
0.02 versus 2.19 ± 0.12 pA/pF (control), 2.31 ± 0.02 
  versus 2.25 ± 0.03 pA/pF (LPS), and 2.33 ± 0.04 versus 
2.28 ± 0.33 pA/pF (DEX) in the absence or presence of 
MgTx, respectively (n = 4–6).
D I S C U S S I O N
As  regulation  of  macrophage  function  involves  ion 
channels, this study was performed to elucidate the 
  influence  of  proinflammatory  and  antiinflammatory 
agents on macrophage Kv channel activity. Here, we de-
scribe, for the first time, that Kv1.3/Kv1.5 heteromeric 
channel expression and their biophysical and pharma-
cological  properties  change  differentially  upon  activ-
ation  and  immunosuppression.  Our  results  have 
physiological relevance indicating that Kv heteromeric 
expression is important as an early regulatory step, and 
that fine-tuning modulation of their expression is cru-
cial to the specific membrane signaling that triggers the 
appropriate immune response. Activated macrophages 
secrete proinflammatory substances like cytokines (e.g., 
TNF-) or NO with potential cellular toxicity (Xaus et 
al., 2001). This release activity is triggered by LPS (Soler 
et al., 2001). In previous work, we showed that LPS and 
TNF-  induce  Kv1.3  in  macrophages  (Vicente  et  al., 
2003, 2005, 2006; Villalonga et al., 2007). Those experi-
ments were designed to characterize the regulation of 
individual channels. However, accumulating evidence 
indicates that Kv1.3 and Kv1.5 associate in mononuclear 
phagocytes  to  generate  distinct  hybrid  channels 
  (Villalonga et al., 2007; Martínez-Mármol et al., 2008; 
Vicente et al., 2008). In the present work, we address 
this issue, characterizing the effects of LPS on the Kv1.3/
Kv1.5 heterotetrameric channel and analyzing biophysi-
cal and pharmacological consequences. Unlike Kv1.5, 
Kv1.3  was  induced;  therefore,  heteromeric  channels 
contain more Kv1.3 units in LPS-activated macrophages 
than in control ones. Because C-type and cumulative in-
activation, which are Kv1.3 hallmarks, need the coopera-
tive interaction of the four subunits (Panyi et al., 1995), 
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Although this pattern is similar to what was observed in 
heterologous expression systems, some differences be-
tween models may exist (Vicente et al., 2006). Many het-
erologous  systems  do  not  express  the  complete 
machinery to recapitulate the native Kv complex. For in-
stance, HEK-293 cells lack the expression of Kv and 
KCNE  regulatory  subunits  that  are  present  in  native 
cells (Uebele et al., 1996; Vicente et al., 2005; Arias et 
al., 2007; Roura-Ferrer et al., 2009; Solé et al., 2009). Di-
verse Kv channels are produced by tetramerization of 
channel  subunits that can be encoded by multiple 
genes. In GH3 pituitary cells, almost all detectable Kv1.4 
is associated with Kv1.5, whereas only 30% of Kv1.5 
protein is present as Kv1.4/Kv1.5 heteromeric channels. 
DEX specifically increases Kv1.5 homomeric channels, 
but not Kv1.4/Kv1.5 heteromeric complexes (Takimoto 
and Levitan, 1996). Thus, hormone induction of one   
K
+  channel  subunit  gene  differentially  influences  ex-
pression  of  cell  surface  homomeric  and  heteromeric 
channels, leading to specific alteration of excitability.   
In  macrophages,  however,  pharmacological  studies 
and amiloride-sensitive osmotic-activated Na
+ channels 
in A549 lung cells and U937 macrophages, respectively; 
these two types of channels are also involved in the os-
motic control (Gamper et al., 2000; Ben et al., 2008).
Unlike  LPS,  which  activates  macrophages  secreting 
proinflammatory substances, GCs, used in the treatment 
of immune-mediated inflammatory diseases, inhibit the 
expression of many inflammatory mediators. GCs, prob-
ably the most powerful endogenous inhibitors of the in-
nate immune reaction across the organism, are mainly 
synthesized in the adrenal medulla and regulate many 
cellular functions with both genomic and nongenomic 
effects. We found that DEX decreased Kv1.3 expression 
without affecting Kv1.5. There is a large body of evidence 
describing discordant DEX effects on channels. Thus, 
DEX increases Kv1.5, but not Kv1.4 and Kv2.1, expres-
sion in pituitary cells in vivo and in vitro (Attardi et al., 
1993). In contrast, Kv3.2 is rapidly down-regulated in 
vivo after corticosterone administration in the hippo-
campus that probably results in enhanced neuroexcit-
ability  (Morsink  et  al.,  2007).  GCs,  also  synthesized 
locally in cardiac cells, induce Kv1.5 in the rat heart ven-
tricle and skeletal muscle, but not in the atrium, lung, or 
hypothalamus (Levitan et al., 1996). We found that DEX 
did not regulate Kv1.5 in macrophages. These results 
  indicate that tissue- and Kv isoform–specific mechanisms 
may  be  underlying  the  corticosteroid  endocrine  res-
ponse. For instance, Takimoto and Levitan (1994) found 
that GCs caused an induction of Kv1.5 gene expression 
in ventricles of adrenalectomized adult rat. Kv1.5 con-
tributes to Islow in mouse ventricular myocytes. Contrary 
to Islow, DEX decreases the density of Ito but maintains 
the  biophysical  properties  and  contributes  to  GC-
  induced action potential prolongation (Wang et al., 
1999).  However,  differential  regulation  of  Kv1.3  and 
Kv1.5 in macrophages leads to molecularly distinct com-
plexes with differentiated biophysical properties. There-
fore, changes in the myeloid lineage, mainly due to the 
heteromeric composition, fine-tune the membrane po-
tential upon immunomodulation.
The relationship between Kv expression and biophysi-
cal and pharmacological parameters clearly indicates a 
trend that fits fairly well with changes in the Kv1.3/Kv1.5 
heterotetrameric ratio. In addition, our findings suggest 
that in macrophages, this is mostly generated by Kv1.3 
regulation rather than a change in Kv1.5 abundance. 
Thus,  although  LPS-induced  activation  increased  the 
Kv1.3/Kv1.5 ratio for 70% of cells, DEX decreased this 
value in 40% (Fig. 8 A). The biophysical and pharmaco-
logical properties were altered in a similar way. The per-
centage of inhibition, calculated as a function of the 
remaining fraction in the presence of 750 pM MgTx, 
the inactivation time constant, and the percentage of 
cumulative inactivation plotted against the normalized 
Kv1.3/Kv1.5 ratio gave Pearson correlation coefficients of   
r = 0.998, r = 0.965, and r = 0.999, respectively (Fig. 8, B–D).   
Figure  8.  Variations  in  the  Kv1.3/Kv1.5  ratio  correlate  with 
changes in biophysical properties of K
+ currents in macrophages. 
(A) Kv1.3/Kv1.5 ratios in Raw cells cultured in the presence or 
absence of LPS and DEX were calculated from real-time PCR ex-
periments in Fig. 4 and standardized to the value of control cells.   
Values are the mean ± SEM of at least three independent exper-
iments. *, P < 0.05 versus control (Student’s t test). (B) Percentage 
of  MgTx  inhibition  plotted  against  the  Kv1.3/Kv1.5  ratio.   
(C) Time constant of inactivation from Fig. 4 () plotted against the 
Kv1.3/Kv1.5 ratio. (D) Percentage of cumulative inactivation plot-
ted against the Kv1.3/Kv1.5 ratio. The Pearson product-moment 
correlation coefficient using a two-tailed p-value was calculated   
(P < 0.0393, P < 0.0355, and P < 0.0116 for A, B, and C, respec-
tively). White (bar or circle), control; black (bar or circle), LPS; 
gray (bar or circle), DEX.  Villalonga et al. 145
fine-tuning the immune response after GC exposure or 
during an insult.
GCs are secreted in stress conditions. Therefore, they 
not only affect the cardiac workload, but also the im-
mune response because they are effective repressors of 
the immune system. Activated GCs are able to interfere 
with several proinflammatory signaling cascades at dif-
ferent levels. Exogenous GCs are used to treat numerous 
inflammatory disorders; however, the mechanisms un-
derlying their actions are incompletely understood. Our 
results could bring some light to this issue because the 
beneficial effects of GCs in antiinflammatory therapies 
are linked to Kv channel–mediated immunosuppression. 
Therefore, the efficacy of GCs in the treatment of inflam-
matory disorders could be due, at least in part, to their 
effects on the expression of Kv1.3 and Kv1.5 channels.
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  demonstrated  that,  contrary  to  pituitary  cells,  homo-
meric Kv1.5 channels are not present (Vicente et al., 
2006, 2008; Villalonga et al., 2007). We therefore assume 
that Kv1.5 form heteromers with Kv1.3 in macrophages 
with  properties  distinct  from  homomeric  complexes. 
Similar conclusions have been made in blood-derived 
dendritic cells in which pharmacological blockade of 
Kv1.3 and Kv1.5, and with stable expression of an adeno-
viral Kv1.X dominant negative, suggests a functional role 
for both proteins (Judge et al., 2006; Mullen et al., 2006). 
However, by silencing Kv1.3, we demonstrated that an 
increase of Kv1.3 subunits, either in homotetrameric or 
heterotetrameric  structures,  were  mainly  responsible 
for the biophysical changes observed during the LPS-in-
duced activation.
Fig.  9  illustrates  several  possible  heterotetrameric 
structures in macrophages upon activation and immun
osuppression.  Macrophages  express  Kv1.3  and  Kv1.5. 
Because MgTx abolished Kv currents regardless of the 
immunomodulatory agent, we can conclude that, simi-
lar to human dendritic cells (Zsiros et al., 2009), Kv1.5 
apparently does not form homomeric complexes. How-
ever, the presence of structures solely formed by Kv1.3 
cannot be ruled out. We have previously shown that, 
based on biophysical, molecular, and pharmacological 
studies, the major Kv channel in Raw macrophages is 
generated by structures where the predominant subunit 
is Kv1.5 (Villalonga et al., 2007). Different Kv1.3/Kv1.5 
ratios are responsible for the biophysical consequences, 
Figure  9.  Diagram  of  major  heterotetrameric  struc-
tures in Raw macrophages upon immunomodulation. 
Raw cells express Kv1.3 and Kv1.5. Because MgTx abol-
ished  Kv  currents,  Kv1.5  does  not  form  homomeric 
complexes. However, molecular, pharmacological, and 
biophysical data indicate that Raw cells express more 
Kv1.5 than Kv1.3. LPS-induced macrophages increased 
the number of Kv1.3 subunits at the complex. However, 
the  immunosuppressant  DEX  decreases  Kv1.3,  which 
generates  Kv1.5-predominant  heteromeric  channels. 
Different Kv1.3/Kv1.5 molecular ratios are responsible 
for the biophysical properties that lead to functional 
consequences during activation and immunosuppres-
sion. White circles, Kv1.3; black circles, Kv1.5.146 Immunomodulation of Kv1.3/Kv1.5 channels
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